Status:
COMPLETED
7-Keto DHEA for the Treatment of PTSD
Lead Sponsor:
Humanetics Corporation
Conditions:
PTSD
Eligibility:
All Genders
18-64 years
Phase:
PHASE2
Brief Summary
The purpose of this research study is to test the effectiveness of 7-Keto DHEA in reducing symptoms of Post-Traumatic Stress Disorder (PTSD).
Detailed Description
The main purpose of the study is to investigate the possible effect of 7-Keto Dehydroepiandrosterone (7-Keto DHEA) on decreasing Post Traumatic Stress Disorder Symptoms (PTSD) in a Veteran population....
Eligibility Criteria
Inclusion
- Veteran status and enrolled for care in the Veteran Health Administration
- Ages 18-64
- Primary diagnosis of PTSD as assess by the clinician administered PTSD scale and independent clinical mental health evaluation
Exclusion
- psychosis
- Dementia
- Active alcohol and/or substance abuse or dependence
- Active suicidal or homicidal ideation
- Medical concerns that would exclude use of 7-Keto DHEA
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT01861847
Start Date
February 1 2013
End Date
December 1 2014
Last Update
October 29 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bay Pines VA Healthcare System
Bay Pines, Florida, United States, 33744